Zhitong Finance App News, Lianhuan Pharmaceutical (600513.SH) issued an announcement. Recently, the company received the “Notice of Approval of the Application for the Marketing of Chemical Ingredients” for the active ingredient bilastine issued by the State Drug Administration. Bilastine is a non-sedative long-acting antihistamine that selectively antagonizes peripheral H1 receptors, and has no affinity for muscarinic receptors and low affinity for other receptors.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Lianhuan Pharmaceutical (600513.SH) issued an announcement. Recently, the company received the “Notice of Approval of the Application for the Marketing of Chemical Ingredients” for the active ingredient bilastine issued by the State Drug Administration. Bilastine is a non-sedative long-acting antihistamine that selectively antagonizes peripheral H1 receptors, and has no affinity for muscarinic receptors and low affinity for other receptors.